Institutional investors purchased a net $579.9 thousand shares of MNOV during the quarter ended December 2016. This may signal that the smart money is gaining interest in this company as the 19.93% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 608.1 Thousand shares of MediciNova Inc
MORGAN STANLEY & CO. LLC Bought 81.0 Thousand shares of MediciNova Inc
D. E. SHAW & CO. LP Bought 55.3 Thousand shares of MediciNova Inc